A flow chemistry approach to norcantharidin analogues

- Tarleton, Mark, Young, Kelly A., Unicomb, Eli, McCluskey, Siobahnn N., Robertson, Mark J., Gordon, Christopher P., McCluskey, Adam

An Ugi-intramolecular Diels-Alder route to highly substituted tetrahydroepoxyisoindole carboxamides

- Gordon, Christopher P., Young, Kelly A., Robertson, Mark J., Hill, Timothy A., McCluskey, Adam

Antigiardial Activity of Novel Guanidine Compounds

- Stevens, Andrew J., Abraham, Rebecca, Young, Kelly A., Russell, Cecilia C., McCluskey, Siobhann N., Baker, Jennifer R., Rusdi, Bertha, Page, Stephen W., O'Handley, Ryan, O'Dea, Mark, Abraham, Sam, McCluskey, Adam

Development of 1,8-naphthalimides as clathrin inhibitors

- MacGregor, Kylie A., Robertson, Mark J., Young, Kelly A., von Kleist, Lisa, Stahlschmidt, Wiebke, Whiting, Ainslie, Chau, Ngoc, Robinson, Phillip J., Haucke, Volker, McCluskey, Adam

Development of second-generation indole-based dynamin GTPase inhibitors

- Gordon, Christopher P., Venn-Brown, Barbara, Robertson, Mark J., Young, Kelly A., Chau, Ngoc, Mariana, Anna, Whiting, Ainslie, Chircop, Megan, Robinson, Phillip J., McCluskey, Adam

Discovery of 4,6-bis(2-((E)-benzylidene)hydrazinyl)pyrimidin-2-amine with antibiotic activity

- Russell, Cecillia C., Stevens, Andrew, McCluskey, Adam, Young, Kelly A., Baker, Jennifer R., McCluskey, Siobhann N., Khazandi, Manouchehr, Pi, Hongfei, Ogunniyi, Abiodun, Page, Stephen W., Trott, Darren J.

Expanding the utility of flow hydrogenation - a robust protocol restricting hydrodehalogenation

- Hizartzidis, Lacey, Cossar, Peter J., Robertson, Mark J., Simone, Michela I., Young, Kelly A., McCluskey, Adam, Gordon, Christopher P.

Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues

- Russell, Cecilia C., Stevens, Andrew, McCluskey, Adam, Pi, Hongfei, Khazandi, Manouchehr, Ogunniyi, Abiodun D., Young, Kelly A., Baker, Jennifer R., McCluskey, Siobhann N., Page, Stephen W., Trott, Darren J.

In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens

- Pi, Hongfei, Venter, Henrietta, Russell, Cecilia C., Young, Kelly A., McCluskey, Adam, Page, Stephen W., Ogunniyi, Abiodum D., Trott, Darren J.

Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells

- Chircop, Megan, Perera, Swetha, Sakoff, Jennette, O'Brien, Terence J., McCluskey, Adam, Robinson, Phillip J., Mariana, Anna, Lau, Hui, Ma, Maggie P. C., Gilbert, Jayne, Jones, Nigel C., Gordon, Christopher P., Young, Kelly A., Morokoff, Andrew

Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model

- Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly A., Mccluskey, Adam, Garg, Sanjay, Sapula, Sylvia S., Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.

Prodrugs of the Archetypal Dynamin Inhibitor Bis-T-22

- Odell, Luke R., Robertson, Mark J., Young, Kelly A., McGeachie, Andrew B., Quan, Annie, Robinson, Phillip J., McCluskey, Adam

Pyrimidine-based inhibitors of dynamin I GTPase activity: competitive inhibition at the pleckstrin homology domain

- Odell, Luke R., Abdel-Hamid, Mohammed K., McCluskey, Adam, Hill, Timothy A., Chau, Ngoc, Young, Kelly A., Deane, Fiona M., Sakoff, Jennette A., Andersson, Sofia, Daniel, James A., Robinson, Phillip J.

Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors

- McGeachie, Andrew B., Odell, Luke R., Mariana, Anna, Whiting, Ainslie, Perera, Swetha, Novelle, Aimee, Young, Kelly A., Deane, Fiona M., Gilbert, Jayne, Sakoff, Jennette A., Chircop, Megan, McCluskey, Adam, Quan, Annie, Robinson, Phillip J., Daniel, James A., Chau, Ngoc, Hill, Timothy A., Gorgani, Nick N., Keating, Damien J., Cousin, Michael A., van Dam, Ellen M.

Pyrimidyn-Based Dynamin Inhibitors as Novel Cytotoxic Agents

- Odell, Luke R., Chau, Ngoc, Russell, Cecilia C., Young, Kelly A., Gilbert, Jayne, Robinson, Phillip J., Sakoff, Jennette A., McCluskey, Adam

Robenidine analogues as gram-positive antibacterial agents

- Abraham, Rebecca J., Stevens, Andrew J., O'Handley, Ryan, McCluskey, Adam, Trott, Darren J., Young, Kelly A., Russell, Cecilia, Qvist, Anastasia, Khazandi, Manouchehr, Wong, Hui San, Abraham, Sam, Ogunniyi, Abiodun D., Page, Stephen W.

Synthesis and anticancer activity of focused compound libraries from the natural product lead, oroidin

- Dyson, Lauren, Wright, Anthony D., Young, Kelly A., Sakoff, Jennette A., McCluskey, Adam

Targeting Glioma stem cells by functional inhibition of dynamin 2: a novel treatment strategy for Glioblastoma

- Luwor, Rodney, Morokoff, Andrew P., Robinson, Phillip J., Chircop, Megan, McCluskey, Adam, Jones, Nigel C., Amiridis, Stephanie, D'Abaco, Giovanna, Paradiso, Lucia, Stylli, Stanley S., Nguyen, Hong P. T., Tarleton, Mark, Young, Kelly A., O'Brien, Terence J.

The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models

- Odell, Luke R., Jones, Nigel C., Daniel, James A., Gorgani, Nick N., O'Brien, Terence J., Robinson, Phillip J., McCluskey, Adam, Chau, Ngoc, Robertson, Mark J., Ambrus, Joseph I., Deane, Fiona M., Young, Kelly A., Whiting, Ainslie, Xue, Jing, Prichard, Kate

Wiskostatin and other carbazole scaffolds as off target inhibitors of dynamin I GTPase activity and endocytosis

- Cossar, Peter J., Cardoso, David, McCluskey, Adam, Mathwin, Daniel, Russell, Cecilia C., Chiew, Beatrice, Hamilton, Michael P., Baker, Jennifer R., Young, Kelly A., Chau, Ngoc, Robinson, Phillip J.